Vontobel Holding Ltd. - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
Vontobel Holding Ltd. ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$180,480
-30.0%
12,000
-45.0%
0.00%
-66.7%
Q4 2022$257,894
+17.8%
21,800
+230.6%
0.00%
+50.0%
Q3 2021$219,000
+0.5%
6,594
+13.8%
0.00%0.0%
Q2 2021$218,000
-21.9%
5,7940.0%0.00%0.0%
Q1 2021$279,000
-72.6%
5,794
-70.2%
0.00%
-33.3%
Q4 2020$1,020,00019,4620.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RA Capital Management 6,880,323$38,633,0002.30%
Eversept Partners, LP 773,501$4,343,2081.35%
Opaleye Management Inc. 612,500$3,439,0001.24%
BRIDGER MANAGEMENT, LLC 2,334,196$13,107,0001.08%
Sofinnova Investments, Inc. 1,733,628$9,734,0000.88%
PURA VIDA INVESTMENTS, LLC 354,719$1,992,0000.34%
683 Capital Management, LLC 400,000$2,246,0000.25%
NEXPOINT ASSET MANAGEMENT, L.P. 649,460$3,646,0000.23%
Artal Group S.A. 900,000$5,054,0000.20%
Frontier Wealth Management LLC 226,750$1,273,0000.19%
View complete list of TG THERAPEUTICS INC shareholders